These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32981151)

  • 1. Oxybutynin in primary hyperhidrosis: A long-term real-life study.
    Almeida ART; Ferrari F; Restrepo MVS; Rocha VB
    Dermatol Ther; 2020 Nov; 33(6):e14344. PubMed ID: 32981151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial.
    Schollhammer M; Brenaut E; Menard-Andivot N; Pillette-Delarue M; Zagnoli A; Chassain-Le Lay M; Sassolas B; Jouan N; Le Ru Y; Abasq-Thomas C; Greco M; Penven K; Roguedas-Contios AM; Dupré-Goetghebeur D; Gouedard C; Misery L; Le Gal G
    Br J Dermatol; 2015 Nov; 173(5):1163-8. PubMed ID: 26114588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
    Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study.
    Campanati A; Gregoriou S; Consales V; Rizzetto G; Bobyr I; Diotallevi F; Martina E; Kontochristopoulos G; Platsidaki E; Offidani A
    Dermatol Ther; 2020 Nov; 33(6):e14039. PubMed ID: 32691938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin.
    Teivelis MP; Wolosker N; Krutman M; Kauffman P; Campos JR; Puech-Leão P
    Clinics (Sao Paulo); 2014 Sep; 69(9):608-14. PubMed ID: 25318092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old.
    Wolosker N; Schvartsman C; Krutman M; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2014; 31(1):48-53. PubMed ID: 23627681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases.
    Wolosker N; Kauffman P; de Campos JRM; Faustino CB; da Silva MFA; Teivelis MP; Puech-Leão P
    Int J Dermatol; 2020 Jun; 59(6):709-715. PubMed ID: 32301117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxybutynin 3% gel for the treatment of primary focal hyperhidrosis in adolescents and young adults.
    Nguyen NV; Gralla J; Abbott J; Bruckner AL
    Pediatr Dermatol; 2018 Mar; 35(2):208-212. PubMed ID: 29334132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].
    Try C; Messikh R; Elkhyat A; Aubin F; Humbert RP
    Rev Med Liege; 2012 Oct; 67(10):520-6. PubMed ID: 23167161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oxybutynin for treating axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Neves S; Munia MA; BiscegliJatene F; Puech-Leão P
    Ann Vasc Surg; 2011 Nov; 25(8):1057-62. PubMed ID: 22023940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
    Teivelis MP; Wolosker N; Krutman M; Milanez de Campos JR; Kauffman P; Puech-Leão P
    Ann Thorac Surg; 2014 Nov; 98(5):1797-802. PubMed ID: 25173719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation and validation of Hyperhidrosis Disease Severity Scale.
    Varella AY; Fukuda JM; Teivelis MP; Campos JR; Kauffman P; Cucato GG; Puech-Leão P; Wolosker N
    Rev Assoc Med Bras (1992); 2016 Dec; 62(9):843-847. PubMed ID: 28001258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Schvartsman C; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2015; 32(5):663-7. PubMed ID: 25490865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of the use of oxybutynin for the treatment of plantar hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Kauffman P; de Campos JR; Puech-Leão P
    Int J Dermatol; 2015; 54(5):605-11. PubMed ID: 25600990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 Jul; 28(5):1106-12. PubMed ID: 24512855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of topical agents and oxybutynin as a therapeutic modality for patients with both osmidrosis and hyperhidrosis.
    Varella AYM; Fukuda JM; Teivelis MP; Pinheiro LL; Mendes CA; Kauffman P; Campos JRM; Wolosker N
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):127-132. PubMed ID: 29641679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.